Topics

Bayer's Nubequa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer

19:00 EST 30 Jan 2020 | BioSpace

The new data should give Bayer’s Nubequa some energy to go after market share held by other drugs approved to treat prostate cancer, including Pfizer’s Xtandi.

Original Article: Bayer's Nubequa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "Bayer's Nubequa Posts Significant OS Data as it Fights for Market Share in Prostate Cancer"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...